20th November 2018 & 21st November 2018
dbb forum, Friedrichstraße 169, 10117 Berlin
1st Day (20.11.2018, Tuesday)
Sabine Weiss, Parliamentary State Secretary to the Federal Minister of Health (BMG), Germany |
Wolfgang Burtscher, Deputy Director-General - Directorate "Research and Innovation" (RTD), European Commission |
Mairead O'Driscoll, ICPerMed Chair, Health Research Board (HRB), Ireland |
Katherine Payne, University of Manchester, United Kingdom |
Introduction and Moderation: Jürgen Wolf, University Hospital Cologne, Germany The genomic approach: Roman Thomas, University of Cologne, Germany |
Monika Frenzel, ICPerMed Secretariat, French National Research Agency (ANR), France |
Introduction and Moderation: Jan-Ingvar Jönsson, Swedish Research Council, Sweden The policy perspective: Jenni Nordborg, National Coordinator Office for Life Science, Sweden |
Etienne Richer, Canadian Institutes of Health Research (CIHR), Canada Catalina Lopez-Correa, Genome British Columbia, Canada |
Keynote 2: Clinical Implementation – Challenges and Solution Strategies Daryl Pritchard, Personalized Medicine Coalition (PMC), United States of America |
Public-public Partnerships for Research in Personalised Medicine, ERA-PerMed Rafael de Andrés Medina, The National Institute of Health Carlos III (ISCIII), Spain |
Miguel Antunes, National Authority of Medicines and Health Products (INFARMED), Portugal |
2nd Day (21.11.2018, Wednesday)
Keynote 3: Precision Medicine: From patient need to providing solutions in clinical practise Thorsten Gutjahr, AstraZeneca, United Kingdom |
Walter Kolch, Systems Biology Ireland |
Introduction and Moderation: Gaetano Guglielmi, ICPerMed Secretariat, Italian Ministry of Health, Italy NAGEN 1000: An example of a Project for Regional Implementation of Personalised Genomic Medicine in Healthcare Proposal of Reccomendations for a National Strategy on personalized Medicine Report In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome |
Introduction and Moderation: Mafalda Bourbon and João Lavinha, INSA, Portugal Mechanism of Diseases and Research Effort: Mafalda Bourbon, INSA, Portugal |
Keynote 4: International view of Personalised Medicine The Chinese perspective: Cong Yu, BGI Group, China |
Mairead O'Driscoll, ICPerMed Chair, Health Research Board (HRB), Ireland |